BCA
ASTH icon

Berman Capital Advisors’s Astrana Health ASTH Stock Holding History

Berman Capital Advisors’s Portfolio ASTH Stock Details ASTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		$3K Buy
+33
New +$2.81K ﹤0.01% 1633

Other funds holding ASTH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Berman Capital Advisors's ASTH Position: Q3 2021 in Review

Berman Capital Advisors opened a new position in Astrana Health (ASTH) in Q3 2021: 33 shares worth $3K. The stake represents ﹤0.01% of the portfolio and ranks #1633 among its holdings.

142 funds tracked by Wall St. Rank hold ASTH as of Q3 2021.

  • Berman Capital Advisors held 33 shares of Astrana Health worth $3K as of Q3 2021.
  • Astrana Health was a new Berman Capital Advisors position in Q3 2021.
  • Astrana Health made up ﹤0.01% of Berman Capital Advisors's portfolio in Q3 2021, its #1633 holding.
  • 142 funds tracked by Wall St. Rank held Astrana Health as of Q3 2021.

Based on Berman Capital Advisors's 13F filing for Q3 2021, filed 7 Oct 2021.